This further facilitates one of the greatest pomegranate benefits for the skin and keeps the skin healthy and glowing
In a 68-week clinical trial, patients treated with GLP-1 experienced an average weight loss of 14.9% from their initial body Trusted Source Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Rubino D, Abrahamsson N, Davies M, et al Go to Source weight
Urinary Tract Infections (UTIs) People can be more likely to get infections in their urinary system
Key Takeaway GLP-1 receptor agonists show real promise for reducing pain, flare frequency, and disease severity in some people with hidradenitis suppurativa, particularly those with obesity or metabolic dysfunction
Looking forward, the GLP-1 drugs we study (semaglutide, tirzepatide, and emerging oral formulations like orforglipron) are likely only the beginning of a new wave of chronic therapies for conditions like obesity, heart failure, and even kidney disease
Maybe you saw it on a supplement shelf